Left-dominant arrhythmogenic cardiomyopathy due to desmoplakin mutation: a case report.
Gustavo A Lemus BarriosJose Patricio Lopez-LopezStephany Barbosa-BalagueraAlejandro Mariño CorreaPublished in: ESC heart failure (2023)
The case of a 49-year-old man with acute onset of heart failure is presented. The initial work-up showed a dilated cardiomyopathy with severely reduced left ventricular ejection fraction. In the differential diagnostic process, hypertensive, ischaemic, and valvular aetiologies were discarded. Subsequently, a cardiac magnetic resonance revealed global hypokinesis and inferior and anterior subepicardial fibrosis. Once differential diagnoses of subepicardial fibrosis (myocarditis, sarcoidosis, and Chagas disease) were discarded, a genetic panel was performed, resulting in a heterozygous mutation of desmoplakin (DSP) gene c.6697_6698del. A left-dominant DSP arrhythmogenic cardiomyopathy mutation was diagnosed. Structural myocardial abnormalities and ventricular arrhythmias characterize arrhythmogenic cardiomyopathy. Up to 50% of cases are associated with mutations in DSP genes (JUP, DSP, and PKP2). DSP is the fundamental component of the desmosome structure and provides structural support through intercellular adhesion. Therefore, when frequent differential diagnoses are discarded, genetic studies for dilated cardiomyopathy and DSP mutation should be considered.
Keyphrases
- heart failure
- left ventricular
- ejection fraction
- aortic stenosis
- genome wide
- magnetic resonance
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- atrial fibrillation
- blood pressure
- dna methylation
- mitral valve
- liver failure
- acute heart failure
- aortic valve
- coronary artery disease
- transcription factor
- escherichia coli
- acute coronary syndrome
- aortic dissection
- transcatheter aortic valve replacement
- hepatitis b virus
- drug induced
- biofilm formation
- liver fibrosis
- bioinformatics analysis